Elite Pharmaceuticals Inc (ELTP)

[namtae]

Just wrapped up a long, very intense & thorough investigation of Elite

Our undisputed, irrefutable conclusion rates Elite as an over bloated, over valued company with serious corporate governance concerns of executive self dealing and a history of misrepresentations in SEC filings. Whether these qualify as fraudulent, we'll leave to the regulators and others currently investigating the company

In conclusion, we rate Elite a strong sell with mid range valuation of $0.014/share

This report is based on sources that we consider reliable. All information contained herein is subject to change without notice. Our professionals may provide oral or written market commentary that reflects opinions that are contrary to the opinions expressed in this report. The price and value of the investment referred to in this report may fluctuate.